United States In Vitro Diagnostics Market Size
According to Straits Research analysis, the United States In Vitro Diagnostics Market was valued at USD 27837.98 Million in 2024 and is projected to reach USD 32197.59 Million by 2028, expanding at a CAGR of 3.9% during the forecast period. The demand is primarily driven by the healthcare and clinical industries, using these diagnostics for disease detection, monitoring, and treatment plan development. Key drivers include the rising prevalence of chronic and infectious diseases, increasing geriatric population, and advanced technology integration into healthcare. Emerging trends in the market are focused on precision medicine, next-generation sequencing, and molecular diagnostics. These technological advancements present a big opportunity for the industry moving forwards. As the largest market globally for In Vitro Diagnostics, the US is effectively positioning itself to lead this industry's technological revolution.
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States In Vitro Diagnostics Market Highlights
- By segment, Reagents and Kits emerged as the largest Product and Services in terms of market size in 2024.
- Reagents and Kits is anticipated to remain the most attractive Product and Services segment, recording the fastest growth during the forecast period.
- In 2024, United States accounted for 33.55% of the global in vitro diagnostics market size.
- By 2028, United States is expected to lead the global in vitro diagnostics market in terms of market size.
- Within North America, United States is projected to dominate the regional in vitro diagnostics market size by 2028.
- Canada is identified as the fastest-growing market in North America, anticipated to reach USD 24106 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope |
Details |
| Base Year for Study |
2024 |
| Study Period |
2020-2028 |
| Historical Period |
2020-2023 |
| Forecast Period |
2025-2028 |
| Market Size In 2024 |
USD 27837.98 Million |
| Market Size In 2028 |
USD 32197.59 Million |
| Largest segment |
Reagents and Kits |
| Fastest segment |
Reagents and Kits |
| Units |
Revenue in USD Million |
| CAGR |
3.9% (2025-2028) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United States In Vitro Diagnostics Market Share By Product and Services
Segmentation Covered
| Segments |
Sub Segments |
| Product and Services |
- Reagents and Kits
- Instruments
- Data Management Software and Services
|
| Technology |
- Molecular Diagnostics
- Clinical Chemistry
- Immunodiagnostics
- Hematology
- Microbiology
- Others
|
| Application |
- Infectious Diseases
- Oncology
- Cardiac Diseases
- Autoimmune Diseases
- Nephrological Diseases
- Diabetes
- Others
|
| End User |
- Hospitals & Clinics
- Standalone Laboratories
- Home Care Settings
- Others
|
United States In Vitro Diagnostics Market By Product and Services 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States In Vitro Diagnostics Market By Technology 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States In Vitro Diagnostics Market By Application 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States In Vitro Diagnostics Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.